Literature DB >> 11706981

Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?

J Honnorat, J C Antoine, M F Belin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11706981     DOI： 10.1002/ana.1270

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

1.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

Review 2.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

3.  Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.

Authors:  J Honnorat; S Cartalat-Carel; D Ricard; J Ph Camdessanche; A F Carpentier; V Rogemond; F Chapuis; M Aguera; E Decullier; A M Duchemin; F Graus; J C Antoine
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154

Review 4.  Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review.

Authors:  Keiko Tanaka; Meiko Kawamura; Kenji Sakimura; Nobuo Kato
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

5.  Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.

Authors:  Sven Jarius; Pedro Martínez-García; Adelaida León Hernandez; Jan Christoph Brase; Kathrin Borowski; Jens Ulrich Regula; Hans Michael Meinck; Winfried Stöcker; Brigitte Wildemann; Klaus-Peter Wandinger
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

6.  Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.

Authors:  Sven Jarius; Madeleine Scharf; Nora Begemann; Winfried Stöcker; Christian Probst; Irina I Serysheva; Sigrun Nagel; Francesc Graus; Dimitri Psimaras; Brigitte Wildemann; Lars Komorowski
Journal:  J Neuroinflammation       Date:  2014-12-11       Impact factor: 8.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.